alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 75, Number 86 (Wednesday, May 5, 2010)]
[Notices]
[Pages 24775-24776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10441]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Advisory Committee on Prosthetics and Special Disabilities 
Programs; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Advisory Committee on Prosthetics and Special Disabilities Programs 
(the ``Committee'') will be held May 4-5, 2010, in Room 930, at VA 
Central Office, 810 Vermont Avenue, NW., Washington, DC. The sessions 
will convene at 8:30 a.m. on

[[Page 24776]]

both days and will adjourn at 4:30 p.m. on May 4 and noon on May 5. The 
meeting is open to the public.
    The purpose of the Committee is to advise the Secretary of Veterans 
Affairs on VA's prosthetic programs designed to provide state-of-the-
art prosthetics and the associated rehabilitation research, 
development, and evaluation of such technology. The Committee also 
provides advice to the Secretary on special disability programs which 
are defined as any program administered by the Secretary to serve 
Veterans with spinal cord injury, blindness or visual impairment, loss 
of extremities or loss of function, deafness or hearing impairment, and 
other serious incapacities in terms of daily life functions.
    On May 4, the Committee will have its annual ethics briefing by the 
Office of General Counsel and be briefed by the Director, Audiology and 
Speech Pathology Service, Chief Consultant for Spinal Cord Injury and 
Disorders, Chief Consultant for Care Coordination, Director of Blind 
Rehabilitation Service, and the Chief Consultant for Mental Health 
Services. On May 5, the Committee will be briefed by the Director of 
VA's Podiatric Services and the Office of Construction and Facilities 
Management.
    No time will be allocated for receiving oral presentations from the 
public. However, members of the public may direct questions or submit 
written statements for review by the Committee in advance of the 
meeting to Mr. Larry N. Long, Designated Federal Officer, Veterans 
Health Administration, Patient Care Services, Rehabilitation Services 
(117D), Department of Veterans Affairs, 810 Vermont Avenue, NW., 
Washington, DC 20420 or by e-mail at <a href="/cdn-cgi/l/email-protection#5f333031333e2d1f293e71383029"><span class="__cf_email__" data-cfemail="95f9fafbf9f4e7d5e3f4bbf2fae3">[email protected]</span></a>. Any member of the 
public wishing to attend the meeting should contact Mr. Long at (202) 
461-7354.

    Dated: April 29, 2010.

    By Direction of the Secretary.
Vivian Drake,
Acting Committee Management Officer.
[FR Doc. 2010-10441 Filed 5-4-10; 8:45 am]
BILLING CODE 8320-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 75, Number 86 (Wednesday, May 5, 2010)]
[Notices]
[Page 24708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10580]



[[Page 24708]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0475]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Administrative Detention and Banned 
Medical Devices

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Administrative Detention and 
Banned Medical Devices'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-5156, 
<a href="/cdn-cgi/l/email-protection#b3f7d2dddad6df9df4dac7c7dfd6c0dcddf3d5d7d29ddbdbc09dd4dcc5"><span class="__cf_email__" data-cfemail="3074515e59555c1e775944445c55435f5e705654511e5858431e575f46">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: In the Federal Register of January 19, 2010 
(75 FR 2871), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0114. 
The approval expires on February 28, 2013. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.

    Dated: April 29, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-10580 Filed 5-4-10; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 99.8

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Minera Andes Inc. (the Corporation) on Form 40-F for the twelve month period ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Henry A. John, Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|      |  |                  |  |                   |  |                        
|----- |  | ---------------- |  | ----------------- |  | -----------------------
|      |  |                  |  | MINERA ANDES INC.
|      |  |                  | 
|Date: |  | October 16, 2008 |  | By:               |  | /s/ Henry A. John      
|      |  |                  |  |                   |  | Henry A. John          
|      |  |                  |  |                   |  | Chief Financial Officer

A signed original of this written statement required by Rule 13a- 14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350 has been provided to Minera Andes, Inc. and will be retained by Minera Andes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 40-F to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to
be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 40-F), irrespective of any general incorporation language
contained in such filing.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                                       0001029850
<NAME>                     Orion Network Systems, Inc.
<MULTIPLIER>                                         1
<CURRENCY>                                   US Dollar
       
<S>                                     <C>      
<PERIOD-TYPE>                                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<EXCHANGE-RATE>                                      1
<CASH>                                      42,187,807
<SECURITIES>                                         0
<RECEIVABLES>                                6,573,316
<ALLOWANCES>                                   100,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                            52,244,526
<PP&E>                                     351,513,496
<DEPRECIATION>                             (68,224,957)
<TOTAL-ASSETS>                             358,264,444
<CURRENT-LIABILITIES>                       63,029,250
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                 20,902,366
<COMMON>                                       112,447
<OTHER-SE>                                    (548,815)
<TOTAL-LIABILITY-AND-EQUITY>               358,264,444
<SALES>                                        500,860
<TOTAL-REVENUES>                            41,847,292
<CGS>                                          376,945
<TOTAL-COSTS>                               78,200,050
<OTHER-EXPENSES>                            25,388,243
<LOSS-PROVISION>                               919,453
<INTEREST-EXPENSE>                          25,450,284
<INCOME-PRETAX>                            (27,111,351)
<INCOME-TAX>                                    84,059
<INCOME-CONTINUING>                        (27,195,410)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (27,195,410)
<EPS-PRIMARY>                                    (2.62)
<EPS-DILUTED>                                    (2.62)
        



</TABLE>
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 24 - 0022 STATE OF MONTANA,

Plaintiff and Appellee, vs. JEFFREY DAVID PIERCE,

Defendant and Appellant .

**G RANT**  Pursuant to authority granted under Mont. R. App. P. 26(1), the Appellant is given an extension of time until April 12, 2024 , to prepare, file, and serve the Appellant’s opening brief.

Electronically signed by: Bowen Greenwood Clerk of the Supreme Court March 6 2024

03/06/2024
Case Number: DA 24-0022
II

106TH CONGRESS

1ST SESSION S. 168

For the relief of Thomas J. Sansone, Jr.

IN THE SENATE OF THE UNITED STATES

JANUARY 19, 1999

Mr. MOYNIHAN introduced the following bill; which was read twice and

referred to the Committee on the Judiciary

A BILL

For the relief of Thomas J. Sansone, Jr.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. COMPENSATION FOR VACCINE-RELATED IN4 JURY.

5 (a) CAUSE OF INJURY.—In consideration of the peti6 tion filed under subtitle 2 of title XXI of the Public Health

7 Service Act (42 U.S.C. 300aa–10 et seq.) (relating to the

8 National Vaccine Injury Compensation Program) by the

9 legal representatives of Thomas J. Sansone, Jr., including

10 the claims contained in that petition that the injury de11 scribed in that petition was caused by a vaccine covered

12 in the Vaccine Injury Table specified in section 2114 of
2

•S 168 IS

1 such Act (42 U.S.C. 300aa–14) and given on June 1,

2 1994, such injury is deemed to have been caused by such

3 vaccine for the purposes of subtitle 2 of title XXI of such

4 Act.

5 (b) PAYMENT.—The Secretary of Health and Human

6 Services shall pay compensation to Thomas J. Sansone,

7 Jr. for the injury referred to in subsection (a) in accord8 ance with section 2115 of the Public Health Service Act

9 (42 U.S.C. 300aa–15).

Æ
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 

 National Institute for Occupational

 Safety and Health 

Robert A. Taft Laboratories

 4676 Columbia Parkway 

Cincinnati, OH 45226-1998 

Phone: 877-222-7570 

Fax: 513-533-6826 

May 7, 2010 

SEC Tracking Number: SEC00163 

Ms. Rachel Leiton 

Division of Energy Employees Occupational 

 Illness Compensation 

U.S. Department of Labor 

Room C-4511 

200 Constitution Avenue, N.W. 

Washington, D.C. 20210 

Dear Ms. Leiton: 

On behalf of the Secretary of the Department of Health and Human Services (HHS), and as required 

by 42 C.F.R. § 83.17(d), I am notifying you of the final effect of the HHS decision to designate a 

class of employees from the Lawrence Livermore National Laboratory in Livermore, California, as 

an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness 

Compensation Program Act of 2000. On April 5, 2010, as provided for under 42 U.S.C. § 7384q(b), 

the Secretary of HHS designated the following class of employees as an addition to the SEC: 

All employees of the Department of Energy, its predecessor agencies, and their 

contractors and subcontractors who worked at the Lawrence Livermore National 

Laboratory in Livermore, California from January 1, 1950 through December 31, 

1973, for a number of work days aggregating at least 250 work days, occurring either 

solely under this employment or in combination with work days within the 

parameters established for one or more other classes of employees in the Special 

Exposure Cohort. 

This designation became effective on May 5, 2010, as provided for under 42 U.S.C. § 7384l(14)(C). 

Hence, beginning on May 5, 2010, members of this class of employees, defined as reported in this 

notice, became members of the SEC. 

Sincerely, 

 Stuart L. Hinnefeld, Interim Director 

 Division of Compensation Analysis and Support 

 National Institute for Occupational Safety and Health
C.J. J.

Douglas 3. J. The petition satisfies the requirements of SCR 98(5). Accordingly, we approve attorney Marcia M. McCormick's resignation. SCR 98(5)(a)(2). The petition is hereby granted.

It is so ORDERED.

/ Hardesty 

### c Li -3 t 

# -Thr Parraguirre J.

Saitta cc: David A. Clark, Bar Counsel Kimberly K. Farmer, Executive Director, State Bar of Nevada Marcia M. McCormick Perry Thompson, Admissions Office, United States Supreme Court SUPREME COURT OF NEVADA 2 (0) 1.947A
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002*





I, David
M. McNamee, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Quarterly Report on Form 10-Q of Bethesda C0801, Inc. for the quarter ended
March 31, 2010 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
that information contained in such Quarterly Report on Form 10-Q Report
fairly presents in all material respects the financial condition and results of
operations of Bethesda C0801, Inc.





Date:
      May 10, 2010
                    By:
                    /s/ David
      M. McNameeDavid
      M. McNameePrincipal
      Executive
                        and
      Principal Financial
Officer





* The
foregoing certification is being furnished solely pursuant to 18 U.S.C. Section
1350 and is not being filed as part of the Report or as a separate disclosure
document.
| 1.     | Such      Quarterly Report of Form 10-Q for the period ending February 28,      2009, fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934; and                                                             |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |
| 2.     | The      information contained in such Quarterly Report on Form 10-Q for      the period ended February 28, 2009, fairly represents in all material      respects, the financial condition and results of operations of Zhong Sen      International Tea Company. |

| Date:       April 7, 2009                      |
|-----------------------------------------------------|
|                                                |
| Zhong      Sen International Tea Company            |
|                                                |
| By: /s/ Binquan      Zhang                     |
| Binquan      ZhangChief Financial      Officer |
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6303

WILLIAM RAY DELOACH,

Plaintiff - Appellant,

versus

STEPHANIE KING; BARBARA WHEELER,

Defendants - Appellees.

Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Samuel G. Wilson, District Judge.

(CA-95-621-R)

Submitted: September 20, 1996 Decided: October 1, 1996

Before NIEMEYER, HAMILTON, and MOTZ, Circuit Judges.

Affirmed by unpublished per curiam opinion.

William Ray Deloach, Appellant Pro Se. Mark Ralph Davis, OFFICE OF

THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals from the district court's order denying

relief on his 42 U.S.C. § 1983 (1994) complaint. We have reviewed

the record and the district court's opinion and find no reversible

error. Accordingly, we affirm on the reasoning of the district

court. Deloach v. King, No. CA-95-621-R (W.D. Va. Feb. 23, 1996).

We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court

and argument would not aid the decisional process.

AFFIRMED
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 04-1696

VICKIE L. MCIVER ROBERTS,

Plaintiff - Appellant,

versus

BAPTIST HOSPITAL AND MEDICAL CENTER, Director,

Employee Relations,

Defendant - Appellee.

Appeal from the United States District Court for the Middle

District of North Carolina, at Durham. Frank W. Bullock, Jr.,

District Judge. (CA-03-397-1)

Submitted: September 15, 2004 Decided: October 5, 2004

Before WILKINSON and TRAXLER, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Vickie L. McIver Roberts, Appellant Pro Se. William Randolph

Loftis, Jr., Kristine Marie Howard, CONSTANGY, BROOKS & SMITH,

L.L.C., Winston-Salem, North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
- 2 -

PER CURIAM:

Vickie L. McIver Roberts appeals the district court’s

order granting Defendant’s motion for summary judgment in her

action under Title VII of the Civil Rights Act of 1964, as amended,

and the Americans with Disabilities Act. We have reviewed the

record and find no reversible error. Accordingly, we affirm on the

reasoning of the district court. See Roberts v. Baptist Hosp.,

Dir., Employee Relations, No. CA-03-397-1 (M.D.N.C. filed May 17,

2004; entered May 18, 2004). We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

AFFIRMED
Exhibit 10.49

Confidential

LOGO

Memorandum



|      |  |                                                
|----- |  | -----------------------------------------------
|To:   |  | David M. Wurzer, Executive Vice-President & CFO
|      | 
|From: |  | Timothy M. Shannon, President & CEO            
|      | 
|Date: |  | December 20, 2007                              
|      | 
|Re:   |  | Addendum to Employment Agreement               

This memo will serve as and Addendum to the Employment Agreement (the Agreement) you executed with
your employer, CuraGen Corporation (the Company), on or about September 1, 2006.

David M. Wurzer (the Executive) and the
Company have agreed to modify the terms of that Agreement as follows, effective January 1, 2008:



| | 1. | (Section 1 A.  Employment; Duties and Responsibilities.)
| | -- | ---------------------------------------------------------

The Company shall employ the Executive, and the Executive shall serve the Company, as Advisor to the Company, with such duties and responsibilities as may be assigned to the Executive by the Chief Executive Officer (CEO)
of the Company and are typically associated with a position of that nature.

Notwithstanding the change of title of Executive from EVP & CFO to
Advisor effective January 1, 2008 as provided above, Executive shall be entitled to all year-end bonuses and other compensation for his role as EVP & CFO for the year ending December 31, 2007 which are consistent with the
Companys Executive Incentive Plan for 2007 for Executive and other senior executives of the Company, except for the Long Term Equity component of the EIP.

Unless explicitly changed in this Addendum, all other terms of the Agreement shall remain in full force and effect.

The parties knowingly and
voluntarily sign this Addendum as of the date set forth below



|                        |  |                     |  |                                                     |  |     |  |                       
|----------------------- |  | ------------------- |  | --------------------------------------------------- |  | --- |  | ----------------------
|                        |  |                     |  | CuraGen Corporation                                
|                        |  |                     |  |                                                    
|By:                     |  | /s/ David M. Wurzer |  |                                                     |  | By: |  | /s/ Timothy M. Shannon
|David M. Wurzer         |  |                     |  | Name:  Timothy M. Shannon Title:    President & CEO
|                        |  |                    
|Date: December 20, 2007 |  |                     |  | Date: December 20, 2007